European Journal of Biomedical and Pharmaceutical Sciences

PROTECT YOUR LIVER FROM HEPATITIS

Amita Tilak*, R. N. Thakur, Sudhir Singh Gangwar and Ranjana Sharma

ABSTRACT

Hepatitis virus infection is a major health problem around theworld and 30% of the world's population display serological indication of current or past infection of hepatitis. Hepatitis B virus is a somewhat double-stranded DNA virus through several serological indicators like HBsAg and anti-HBs, HBe Ag and anti-HBe, and anti-HBc IgM and IgG. HBsAg and anti-HBs, HBe Ag and anti-HBe, and anti-HBc Ig M and Ig G. Hepatitis is an inflammation disease that occour in our liver. It may be produced by drugs, alcohol, or convinced medical conditions. But in maximum cases, it's caused by a virus. This is documented as viral hepatitis, and the most general forms are hepatitis A, B, and C. Hepatitis signals to an inflammation of the liver cells that damage to the liver. There are varied types and causes, but the suggestions can be similar Antiviral actions for chronic hepatitis B consist of interferon (IFN) therapy and nucleoside equivalents like (lamivudine, adefovir, and entecavir therapy. Handling strategies are categorical constructed on the patient age, viral load, presence/absence of HBe Ag, and development of fibrosis.

Keywords: Hepatitis B, DNA virus, inflammation, IgM and IgG, viral hepatitis.